ContextLogic Holdings Inc. (LOGC) stock intrinsic value fair value estimate & owner earnings analysis

WHAT THE COMPANY IS. ContextLogic used to own the Wish shopping app. It sold that business to Qoo10 in April 2024 and kept about $160 million of cash and about $2.9 billion of tax losses. On February 26, 2026 its subsidiary, ContextLogic Holdings LLC, bought US Salt for about $908 million. US Salt was founded in 1893 and runs one evaporated-salt plant in Watkins Glen, New York, which has more than 40 years of salt reserves plus decades of further undeveloped resource. It sells private-label round-can table salt (it supplies most of the large North American retailers' store brands), food-grade salt, pool and water-softener salt, and pharmaceutical-grade salt. It believes it is one of only two US producers of pharmaceutical-grade salt at scale. Salt is cheap to make and expensive to ship, so competition is regional and imports matter little. The business is old, steady and hard to replicate. US industry volumes of evaporated salt grew only 0.1% a year from 1998 to 2023, so growth comes from price, not volume. One customer accounts for about 13-14% of sales. HOW IT IS FINANCED. The capital structure decides this valuation. Paying for US Salt took a $215 million term loan (SOFR plus 4.00-4.50%, about 8% today, maturing February 2033, with no financial maintenance covenant on the term loan), the company's own cash, new ContextLogic shares sold or issued at $8, and about $440 million of convertible preferred units issued by the Holdings subsidiary to BC Partners, Abrams Capital and the selling owners. Those preferred units rank ahead of ContextLogic's stake. They accrue 8% a year, compounding, and can convert into Holdings common units at $8, or be redeemed at accrued value at Holdings' option from early 2031. We estimate the accrued preferred claim at about $465 million today. Because it compounds at 8%, faster than the business can grow, we value it at about $504 million, assuming Holdings redeems it at its first opportunity in 2031. ContextLogic's shareholders own what is left after the lenders and these preferred holders. EARNING POWER. Only seven months of combined results exist, so we built normal earning power from US Salt's own audited history. In 2025 US Salt earned $47.9 million of EBITDA on $132.1 million of sales, up from $43.0 million on $123.1 million in 2024. Capital spending was $7.6 million in 2025 and $13.4 million in 2024. Under the new owners, corporate overhead and stock pay add about $8 million a year: in the June 2026 quarter, cash G&A and stock compensation rose about $2 million against the prior year. June-quarter sales were flat at $33.6 million, with prices up 7.7% and volumes down 8%, and EBITDA excluding $1.8 million of deal costs fell from $13.7 million to $9.8 million. Allowing for that overhead, normal EBITDA comes out at about $35-40 million, and about $36 million is our central figure. After roughly $8.5 million of upkeep capital spending, the business generates about $27.5 million a year before interest. That is the median of the 2024 level (about $21 million), the 2025 level (about $33 million) and the current-year run rate. The $2.9 billion of tax losses should keep ContextLogic's share of these profits tax-free for decades, so we value the cash flow before tax. We added back the large amortization of the $388 million of acquired intangibles because it is a bookkeeping charge, not cash. To offset that, we credited no volume growth. The company quotes a higher 'Adjusted EBITDA' of $55.3 million for 2025, but we did not use it because it adds back costs we cannot confirm will stop. If part of those costs really were one-time charges from the 2025 sale process, the bull case covers that. GROWTH. US Salt's 2025 cash flow grew sharply over 2024, mostly because capital spending fell, but the latest quarter went backward. So the base case assumes no growth in the first year. After that we credit only price increases in line with inflation, which the business has shown it can achieve: sales rose 7% in 2025 and prices rose 7.7% in the latest quarter. We gave no credit for management's plans for pharmaceutical mix, new products or new channels, or for future acquisitions, because none of these has been achieved yet. THE CASES (all discounted at 6%). Base: $27.5 million a year, flat in year one, then 2% growth for nine years and 1% after that, over the roughly 50-year life of the reserves and resources. The business is worth about $537 million. Debt is $215 million plus about $23 million for the term loan costing roughly 2 percentage points more than our 6% rate, for $238 million in total. That leaves about $299 million for all the equity holders, about $206 million short of the preferred claim. Bear: the June-quarter volume loss persists and the 14% customer comes under pressure. EBITDA settles near $32 million and capital spending moves back toward $10 million, giving $22 million a year with no growth over the 40-year reserve life. The business is worth about $331 million and owes about $245 million including the cost of refinancing, leaving $86 million against a preferred claim of about $504 million. Interest of about $18 million is still covered, so the lenders are paid, but the preferred holders take everything. Bull: some of the 2025 add-backs prove to be genuinely one-time, EBITDA holds near $43 million after overhead, and pricing continues: $35 million a year growing 3.5% for a decade and 2% after. The business is worth about $856 million, or $621 million after debt, which is about $117 million more than the preferred claim, or about $2.55 per ContextLogic share. WHAT THE SHARES APPEAR TO BE WORTH. On our numbers the common shares have value only in the bull case. In the base and bear cases, what US Salt is worth after its debt is less than the claim of the 8% preferred units that rank ahead of ContextLogic. The negative figures, about -$4.49 a share in the base case and -$9.12 in the bear case, show by how much the preferred claim exceeds what is left. A shareholder's loss is limited to the amount paid for the shares, but these figures mean there is nothing left for the common in those outcomes. The core issue is price: about $908 million for a business we think earns about $27.5 million a year before interest. Because the preferred compounds at 8% while the business grows nearer 2%, the gap widens each year the preferred stays outstanding. WHAT WOULD MAKE THIS ESTIMATE WRONG. US Salt's earnings might return to the 2025 level and keep rising with price, as in the bull case. The company's adjusted figures might prove to reflect real recurring earning power. Holdings might retire the preferred early on better terms. Or the company might buy further businesses cheaply. Holdings' exact share count and some first-month items after closing (the March 2026 stub period carried about $21 million of deal costs and other one-off charges) could not be fully reconciled from the filings. They do not change the conclusion, because in every case except the bull the value turns on the preferred claim, not the share count.